EMA Recommends First Long-Acting Injectable HIV Treatment
The first long-acting injectable treatments for HIV were recommended for marketing approval on October 16 by the European Medicines Agency (EMA). A combination injection of two new antiretroviral (ARV) medicines, rilpivirine (Rekambys) and cabotegravir…
Continue Reading
EMA Recommends First Long-Acting Injectable HIV Treatment